The function of regulatory T cells (T reg cells) has been attributed to a growing number of diverse pathways, molecules and processes. Seemingly contradictory conclusions regarding the mechanisms underlying T reg cell suppressive activity have revitalized skeptics in the field who challenge the core validity of the idea of T reg cells as central immune regulators. However, we note that a consensus may be emerging from the data: that multiple T reg cell functions act either directly or indirectly at the site of antigen presentation to create a regulatory milieu that promotes bystander suppression and infectious tolerance. Thus, the versatility and adaptability of the Foxp3 + T reg cells may in fact be the best argument that these cells are 'multitalented masters of immune regulation'.
tions of T reg cells, including the CD4 + CD25 + Foxp3 + cells, interleukin 10 (IL-10)-producing 'Tr1' cells 10 , transforming growth factor-β (TGF-β)-producing T helper type 3 cells 11 , CD8 + T suppressor cells 12 , natural killer T cells 13 , CD4 -CD8 -T cells 14 and γδ T cells 15 . Some of these T reg cells, such as the CD4 + Foxp3 + cells, originate in the thymus during ontogeny and are referred to as 'natural' T reg cells. T reg cells can also be induced from naive T cells in the periphery 16 . Some but not all of these peripherally induced 'adaptive' T reg cells also express Foxp3. Now it is rare to find a high-profile journal that does not include a new functional activity ascribed to T reg cells. This explosion of molecules, processes, mechanisms of action and phenomenology has led to an undercurrent of cynicism in the field. In this review, we will attempt to make some sense of many (although not all) of the reported functions of T reg cells. We will focus our discussion on Foxp3 + CD4 + natural T reg cells (which develop in the thymus) because these cells are central for immune homeostasis, as illustrated by the fatal consequence of their absence from mice deficient in IL-2, CD25 or Foxp3 or of their depletion from normal adult mice [7] [8] [9] 17, 18 . Notably, like mice, humans with mutations in FOXP3 develop multiorgan autoimmune diseases with fatal consequences 19 .
Many investigations have firmly established the involvement of natural T reg cells in controlling autoimmunity, inflammatory disorders such as asthma and colitis, and immune responses to tissue transplants, tumors and various infectious agents 20 . T reg cells are purported to use many cellular processes to control immune responses. However, to fully consider the varied mechanisms of action of T reg cells, it is critical to consider the two core T reg cell-mediated phenomena: bystander suppression and infectious tolerance.
Although the suppressive activity of T reg cells requires their prior activation through their T cell receptor, once activated, T reg cells suppress in an antigen-nonspecific way called 'bystander suppression' . Thus, T reg cells with one antigen specificity can suppress effector T cells (T eff cells) with many other distinct antigen specificities.
The phenomenon of infectious tolerance is proposed on the basis of in vivo transfer studies in which one population of suppressor T cells creates a regulatory milieu that promotes the outgrowth of a new population of T reg cells with antigen specificities distinct from those of the original T reg population. For example, in the setting of transplantation and type 1 diabetes, the tolerant state induced by T reg cells is maintained even after loss or removal of the original T reg cell population 21, 22 . Furthermore, new antigen specificities can be acquired by adaptive T reg cell populations as long as the new antigen is present on the same tissue that the antigen recognized by the original T reg cells was 21 . Thus, through the processes of bystander suppression and infectious tolerance, T reg cells effectively establish a state of dominant and stable tolerance.
Investigations of the mechanisms of T reg cell function have identified not one or two but an ever-growing list of molecules and processes that contribute to T reg cell-suppressive activities ( Table 1) . Most of these studies have relied on the widely used in vitro suppression assay and a limited number of in vivo disease models. Three complementary approaches have been used to define T reg cell functional biology by examining the influence of T reg cells on other T cells or on antigen-presenting cells (APCs) or by molecular characterization of T reg cell-derived suppressive molecules.
T reg cells influence other T cells
Both in vitro and in vivo analyses suggest that T reg cells can suppress the proliferation and/or cytokine production of T eff cells. Additionally, T reg cells prevent CD8 + cells from differentiating into cytolytic effector cells in vivo without affecting their proliferation or interferon-γ (IFN-γ) production 23 . Because the suppression of T eff cell proliferation by T reg cells was observed in vitro in an APC-free system, it was suggested that T reg cells suppress through direct contact with T eff cells 24 . A mechanism to explain the contact dependence of in vitro suppression has been proposed in a publication showing that T reg cells have large amounts of cytoplamic cAMP and could deliver this potent immunosuppressive compound to T eff cells by contact through gap junctions 25 . Other studies have shown that T reg cells can kill T eff cells directly in culture through the release of granzyme B and perforin [26] [27] [28] [29] . However, imaging studies have shown that T eff cells and T reg cells do not interact stably during suppression in vivo and in vitro 30, 31 .
Because natural T reg cells constitutively express CD25, the high-affinity receptor for IL-2, it has long been suspected that T reg cells suppress by 'sopping up' IL-2 produced by T eff cells thereby preventing their proliferation and differentiation. This hypothesis has been revisited in studies examining the physiological changes in T eff cells after their encounter with T reg cells 32 . T eff cells undergo apoptosis after being exposed to T reg cells. This form of T eff cell death is distinct from those mediated by granzyme B or perforin mentioned earlier and is dependent on the proapoptotic factor Bim, expressed by T eff cells. Preventing Bim-mediated cell death by either Bim deficiency or forced expression of Bcl-2, a protein shown to counteract the proapoptotic activity of Bim, renders the T eff cells resistant to T reg cell-mediated suppression in vitro and in vivo. In this context, it is notable that the galectins also mediate cell death by a perforin-and granzyme-independent mechanism, which suggests a potential link between these two pathways 33, 34 . Unfortunately, it is difficult to explain bystander suppression or infectious tolerance in vivo on the basis of these T eff cell-killing activities.
In contrast, some studies suggest that T reg cells can alter the differentiation of other T cells. For example, CD4 + T eff cells differentiate into IL-10-or TGF-β-producing adaptive T reg cells in the presence of T reg cells in vitro and in vivo, an observation more consistent with the idea of bystander suppression and infectious tolerance [35] [36] [37] .
T reg cells alter APCs
A second approach to defining T reg cell function has been to evaluate their effect on APCs. It has been shown that T reg cells directly interact with antigen-presenting dendritic cells (DCs) in vivo within hours of transfer. The interaction of T reg cells with DCs profoundly affects the ability of T eff cells to subsequently engage and become activated by the same DCs. T reg cells either abrogate the antigen-presenting activity of the DC or promote the secretion of suppressive factors by the target DC population. It has been shown that T reg cells can stimulate APCs to upregulate the activity of indoleamine 2,3-dioxygenase (IDO), a potent immunosuppressive enzyme associated with pregnancy and tumor immune evasion 38, 39 . In those studies, IDO induction was found to depend on high expression of the inhibitory receptor CTLA-4 on T reg cells 40 . However, there is no clear evidence of the involvement of IDO in T reg cell function in vivo or in vitro. The effect of CTLA-4 on T reg cell function is also complex. Blocking CTLA-4 has no effect on in vitro suppression by T reg cells, and in most circumstances, T reg cells from CTLA-4-deficient mice show suppressive activity similar to that of cells from their wild-type littermates 41, 42 . However, in vivo CTLA-4 blockade abrogates T reg cell-mediated suppression in mouse models of inflammatory bowl disease (IBD), autoimmune gastritis and transplantation ( 44 . These findings suggest that T reg cells rely not on one mechanism for their function but instead use many alternative mechanisms to control unwanted autoimmune and uncontrolled adaptive immune responses. Another relevant observation is the potential of T reg cells to activate TGF-β on the surfaces of DCs. Latent TGF-β binds to DCs through interaction with α V β 8 integrins on the basis of an Arg-Gly-Asp motif. This binding is essential for the provision of a substrate for TGF-β activation and prevention of colitis 45 . Evidence has been presented that furin, an enzyme purported to cleave latent TGF-β, is made by T cells after stimulation with IL-12 and thus might influence the creation of inflammatory and regulatory milieus 46 . Additionally, TGF-β, together with a subpopulation of DCs, promotes the differentiation of T eff cells into Foxp3 + T reg cells 47 . Thus, elaborate cross-talk between T reg cells and DCs lead to DC silencing, local TGF-β activation and expansion of the T reg cell repertoire, all of which help to actively establish and reinforce immune quiescence and self-tolerance.
T reg cell-derived suppressor molecules
A third and perhaps the most straightforward approach to understanding T reg cell biology has been to identify T reg cell-specific molecules that are directly responsible for their potent tolerogenic effect. Like the other two approaches, this approach has led to complex and contradictory results. Many studies seem to definitively describe a mechanism of action that is essential for T reg cell function, whether IL-10, TGF-β, CTLA-4, granzyme B, perforin, IFN-γ, IL-9, heme oxygenase-1 (HO-1), cAMP, CD39, galectins or IL-35 ( Table 1) . Yet with the possible exception of CTLA-4 and TGF-β (the latter of which is also essential for T reg cell development), disruption of the genes encoding these molecules does not result in the catastrophic effects found in T reg cell-deficient mice. In an effort to categorize the various pathways and perhaps identify common characteristics, several are summarized below (Fig. 1) .
Many studies have shown that T reg cells can make suppressive cytokines such as IL-10 and TGF-β. Early in vitro studies demonstrated that neutralizing antibodies to IL-10 or TGF-β do not block T reg cell activity and that T reg cells from mice lacking IL-10 or TGF-β show similar suppressive activity 24, 41, 48 . It should be pointed out, however, that although often dismissed, there were some early suggestions that TGF-β is involved in T reg cell suppressive function in vitro 49, 50 . In contrast to those in vitro studies, it has been found that neutralizing IL-10 or TGF-β abolishes T reg cell suppression in vivo in mouse models of IBD, type 1 diabetes, leishmania skin infection and transplantation ( Table 1) . In a few in vivo models, expression of IL-10 or TGF-β specifically in T reg cells is required for T reg cell function [51] [52] [53] . However, in some other situations, the source of these suppressive cytokines is not limited to T reg cells 37, 54, 55 .
HO-1, which catalyzes the formation of carbon monoxide through heme degradation, has been linked to T reg cell function 56, 57 . Similarly, CD39 and CD73, which are 'preferentially' expressed on the surfaces of T reg cells, catalyze the generation of adenosine from the extracellular nucleotide ATP or ADP 58 . Adenosine can bind to its receptor A2A expressed on T eff cells to suppress their responses. Additionally, it has been suggested that several members of the galectin family of carbohydrate-binding proteins are involved in T reg cell function [59] [60] [61] . It has also been proposed that another cytokine, IL-35, is responsible for 
The 'big picture'
Although the results presented above seem overwhelming and confusing at first glance, the following theme emerges from the vast array of data obtained in various disease settings: T reg cells probably use many mechanisms to control unwanted immune responses in vivo. Depending on the nature of the immune response, the eliciting agent, the immunological makeup of the host and the site of suppression, certain mechanism(s) may seem to dominate.
This phenomenon is most vividly exemplified by the IBD model 63 . Reliance on IL-10 for T reg cell-mediated control of IBD varies depending on how the disease is elicited and the timing of T reg cell treatment. Control of more aggressive forms of disease induced by memory T cells or pathogenic bacteria and reversion of established disease requires IL-10 in addition to CTLA-4 and TGF-β. In contrast, in the absence of one of the suppressive mechanisms (such as CTLA-4), T reg cells rely more on alternative suppressive functions such as IL-10 and TGF-β in vitro and in vivo 42, 43 . Thus, it is possible that T reg cell-mediated control of IBD, a disease at the highly inflammation-prone mucosal surface, may require a wider array of suppressive mechanisms operating in synergy and thus that the presence of IL-10, TGF-β, CTLA-4, and IL-35 as well as IL-2 deprivations are necessary for complete protection. This scenario is mirrored in the transplant setting. Immune responses to organ transplants are one of the most vigorous forms of immune responses because of the exceptionally high frequency of alloreactive T cells. Thus, T reg cells may depend on many suppressive mechanisms working in concert to keep alloimmune responses under control. In contrast, one or two mechanisms may suffice to control slowly progressing organ-specific autoimmune diseases such as type 1 diabetes and autoimmune gastritis. In these disease settings, when one pathway is blocked, alternative mechanisms may fully compensate; therefore, T reg cell function might not be dependent on any one particular mechanism.
The site of T reg cell action in vivo is certainly not limited to lymphoid organs. T reg cells have been detected at sites of inflammation, and in many situations, their ability to migrate to and remain in inflamed tissues is important for their function in vivo 50 . Moreover, the molecular mechanisms of suppression used by T reg cells seem to differ depending on their localization in nonlymphoid versus lymphoid tissues. T reg cell-mediated prevention of IBD induced by the transfer of naive T cells is confined to lymphoid organs and is dependent on TGF-β and CTLA-4. In contrast, T reg cell-mediated control of colitogenic bacteria-induced IBD requires the presence of T reg cells in lymph nodes and in the inflamed colon, as well as IL-10 (ref. 64 ). In addition, control of an acute immune response to leishmania is located mainly in lymphoid organs and is independent of IL-10, whereas control of a chronic immune response in the infected skin requires local retention of T reg cells and their production of IL-10 (ref. 64 ). Finally, tumor-infiltrating T reg cells suppress tumor immunity by a mechanism dependent on TGF-β and IL-10, unlike T reg cells isolated from the peripheral blood of the same person 65 . These data from various disease models collectively demonstrate differential requirements for distinct suppressive functions of T reg cells at different tissue sites. In general, T reg cells rely on more suppressive mechanisms to control responses at sites of inflammation than in lymphoid organs.
On the basis of the experimental evidence collected so far, we propose a three-tiered 'sequential' model of T reg cell function in vivo (Fig. 1) . In the steady state, T reg cells exert 'homeostatic control' over the immune system in lymphoid organs to prevent the potential outgrowth of autoreactive T cells. By virtue of their constitutive expression of CD25, T reg cells effectively 'sop up' IL-2 produced by T eff cells, thereby terminating local incidental T eff cell activation while boosting T reg cell fitness and function. This phenomenon helps to explain some of the antigen-nonspecific functions of T reg cells noted in several in vivo systems. T reg cells also function in an antigen-specific way. The T reg cell antigen receptor repertoire is skewed toward recognition of self antigens 66 . In addition, T reg cells show greater sensitivity to antigens than do their T eff cell counterparts 47, 67 . These properties allow T reg cells to effectively patrol the lymphoid organs to prevent potential priming of autoreactive T cells. Most likely the type of T reg cell target in this setting is self antigen-presenting DCs. This contention is supported by the observation that T reg cells are stably conjugated with tissue antigen-bearing DCs during in vivo suppression in lymph nodes. In addition, complete T reg cell ablation in adult mice leads to the expansion of populations of activated DCs and to subsequent fatal multiorgan autoimmune disease 18 . The molecular mechanisms used by T reg cells during this stage probably involve TGF-β and CTLA-4, as suggested by the IBD studies mentioned above 63 . In addition, the massive lymphoproliferation noted in CTLA-4-deficient and TGF-β-deficient mice also supports the idea of an essential function for T reg cells in normal immune homeostasis 68, 69 . Other mechanisms involving IL-10, IDO, HO-1 and CD39-CD73 may also contribute to T reg cell function at this stage, but they are probably not essential, as indicated by the lack of overt changes in immune homeostasis in their absence. It is notable that one attribute of the galectins is their ability to bind to multiple ligands and soluble molecules because of the 'sticky' nature of the lectin moieties. Thus, it is possible that the galectins, by forming functional scaffolds that bind several of the small molecules purported to be mediators of T reg cell suppression, help to establish a local immunosuppressive milieu that influences many cell types, such as T eff cells, DCs, macrophages and B cells, to actively maintain immunological quiescence.
When steady-state self-tolerance is breached, as after Toll-like receptor engagement during infection 70 and in the presence of heightened frequencies of self-reactive T eff cells in autoimmune and transplantation settings, T reg cells become further activated to engage the second tier of 'damage control' . After being activated, T reg cells shed CD62L and upregulate the chemokine receptors and adhesion molecules needed to leave lymphoid organs and gain entry into inflamed tissues. Once in inflamed tissue, T reg cells reactivated by tissue DCs upregulate CD25 and therefore become more effective at competing with T eff cells for IL-2. Activated T reg cells express more IL-10, CTLA-4, IL-35, TGF-β, HO-1 and CD39-CD73 and so are more potent suppressors. In addition, chronically activated T reg cells have high expression of cytotoxic granules such as granzyme B, which enable T reg cells to actively kill APCs and T eff cells in extreme conditions that lead to resolution of the immune response.
Infectious tolerance is established during the final stage to stabilize the tolerant state. Tissue destruction associated with the immune response leads to the presentation of newly exposed tissue antigens on the T reg cell-silenced DCs. Together with TGF-β, also a byproduct of immune activation, these tolerogenic DCs induce the differentiation of T eff cells into adaptive T reg cells, thus expanding the T reg cell antigen receptor repertoire. In the intestine, it has been shown that CD103 + DCs have the unique ability to induce adaptive T reg cells because of their ability to produce retinoic acid, which is needed to induce naive T cells to differentiate into Foxp3-expressing T reg cells 47 . TGF-β induces CD103 expression 45 ; thus, TGF-β may contribute to the induction and/or maintenance of these specialized DCs. This model is consistent with the 'hygiene hypothesis' , proposed to explain the reciprocal rates of infection and atopic and autoimmune disease. Improved hygienic standards and a decrease in both infections and the resulting active immune responses may also deprive people of the opportunity to expand T reg cell antigen receptor repertoires through infectious tolerance and thereby lead to higher rates of allergy and autoimmune disease.
Overall, T reg cells probably use many mechanisms in vivo to prevent and terminate immune responses and to establish a regulatory milieu that will promote a long-lasting, durable state of tolerance. Short-range mechanisms such as cytokine deprivation and the secretion of molecules such as IL-10, adenosine, IL-35, galectins and carbon monoxide 'shut down' local T eff cells during adaptive immune responses. These pathways are designed to act quickly and locally and in many cases are sufficient to dampen immunity. However, in the long term, T reg cells create a regulatory environment by producing TGF-β and/or by substantially changing DC functions to promote new T reg cell production. These processes promote bystander suppression and are critical to the creation of infectious tolerance that can spread beyond the local tissue and exert long-lasting influence over the immune system. It is notable that the some of the mechanisms that T reg cells use to suppress immunity also enhance T reg cell function. For example, by 'sopping up' IL-2, T reg cells simultaneously starve T eff cells and promote their own population expansion and survival. Similarly, the direct or indirect production of TGF-β by T reg cells 'feeds back' to stabilize and enhance Foxp3 expression in T reg cells, thereby boosting their suppressive function.
Concluding remarks
In conclusion, in vitro and in vivo T reg cell function cannot be attributed to a single dominant pathway or molecule. Instead, T reg cells use many suppressive mechanisms that can target various cell types depending on the circumstances and their surroundings. The versatility and adaptability of T reg cells makes them true 'masters of immune regulation' . The chief function of T reg cells in a normal person is to maintain immune homeostasis in the lymphoid organs. After the onset of an immune response, T reg cells use additional suppressive strategies to resolve inflammation and limit tissue damage. The dynamic interaction between T reg cells and DCs is vital for T reg cell function. This model provides a conceptual framework for the ongoing quest to discover more suppressive mechanisms used by T reg cells, which are intricately involved in the pathogenesis of autoimmune disease, infectious disease, cancer and the rejection of transplanted organs. Better understanding of their biology will create opportunities for the development of new therapeutic intervention in these disease settings.
